Long-term effects of cladribine tablets on MRI activity outcomes in patients with relapsing–remitting multiple sclerosis: the CLARITY Extension study

Background The CLARITY and CLARITY Extension studies demonstrated that treatment of relapsing–remitting multiple sclerosis (RRMS) with cladribine tablets (CT) results in significant clinical improvements, compared with placebo. This paper presents the key magnetic resonance imaging (MRI) findings fr...

Celý popis

Podrobná bibliografie

Vydáno v:	Therapeutic advances in neurological disorders Ročník 11; s. 1756285617753365
Hlavní autoři:	Comi, Giancarlo, Cook, Stuart, Rammohan, Kottil, Soelberg Sorensen, Per, Vermersch, Patrick, Adeniji, Abidemi K., Dangond, Fernando, Giovannoni, Gavin
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	London, England SAGE Publications 01.01.2018 SAGE PUBLICATIONS, INC SAGE Publishing
Edice:	Therapeutic Advances in Neurological Disorders
Témata:	Life Sciences Magnetic resonance imaging Multiple sclerosis NMR Nuclear magnetic resonance Original Research relapsing–remitting multiple sclerosis magnetic resonance imaging cladribine extension study relapsing-remitting multiple sclerosis
ISSN:	1756-2864, 1756-2856, 1756-2864
On-line přístup:	Získat plný text
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!